Ameluz 78 mg/g
Ameluz 78 mg/g is a medicine authorised by Swissmedic under authorisation number 65693. The authorisation holder is Louis Widmer AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 November 2015 and the authorisation is valid without a time limit. ATC code L01XD04 places the medicine in the group Antineoplastic agents.
| Authorisation number | 65693 |
|---|---|
| Name | Ameluz 78 mg/g |
| Full name | Ameluz 78 mg/g, Gel |
| Authorisation holder | Louis Widmer AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | L01XD04 |
| First authorisation | 26 November 2015 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ameluz 78 mg/g, Gel | B | 26 November 2015 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 2 | g | L01XD04 | 07.16.4. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ameluz 78 mg/g authorised in Switzerland?
Yes. Ameluz 78 mg/g is authorised by Swissmedic under authorisation number 65693, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ameluz 78 mg/g have?
Ameluz 78 mg/g is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ameluz 78 mg/g?
The authorisation holder is Louis Widmer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.